Home / Southeast Asia / IDN

Indonesia

Indonesia's national HIV reporting system, SIHA, cannot be reached by the public, so Indonesia appears through international and donor reporting. Our project also reads reports from community-led monitoring at a small number of selected facilities, where service users report stockouts, interruptions, staffing and out-of-pocket cost. The facilities are a small sample and do not represent Indonesia as a whole.

560,000

People living with HIV, 2025

WHO Global Health Observatory

48.0%

On antiretroviral treatment, 2025

WHO Global Health Observatory

$4.2m

United States HIV disbursements, 2026

ForeignAssistance.gov

$36.1m

External HIV financing, all donors, 2024

OECD Creditor Reporting System

External HIV financing

OECD CRS · ForeignAssistance.gov

All donors
United States, OECD record
The Global Fund
United States, self-reported

Year	All donors	United States, OECD record	The Global Fund	United States, self-reported
2001	—	—	—	$1.9m
2002	$2.5m	$926k	—	$5.1m
2003	$13.4m	$8.4m	$936k	$8.0m
2004	$17.4m	$9.1m	$1.6m	$11.2m
2005	$48.7m	$9.1m	$9.9m	$9.7m
2006	$55.1m	$8.2m	$15.7m	$8.4m
2007	$32.3m	$9.4m	—	$8.8m
2008	$35.1m	$9.1m	$10.9m	$9.4m
2009	$52.6m	$9.2m	$21.7m	$9.2m
2010	$43.6m	$4.0m	$25.9m	$4.9m
2011	$58.4m	$6.6m	$33.7m	$5.8m
2012	$59.7m	$10.6m	$22.8m	$10.5m
2013	$66.2m	$10.2m	$38.6m	$10.0m
2014	$46.8m	$10.1m	$18.4m	$10.1m
2015	$40.2m	$8.7m	$18.1m	$9.8m
2016	$40.1m	$8.1m	$27.1m	$8.9m
2017	$80.4m	$9.9m	$70.0m	$9.7m
2018	$33.9m	$11.0m	$19.6m	$8.6m
2019	$34.4m	$8.2m	$25.5m	$8.2m
2020	$36.5m	$8.3m	$26.4m	$7.9m
2021	$48.6m	$14.0m	$33.9m	$-25.2m
2022	$28.0m	$10.0m	$17.5m	$14.6m
2023	$75.4m	$10.0m	$63.0m	$9.5m
2024	$36.1m	$9.9m	$26.0m	$10.6m
2025	—	—	—	$6.6m
2026	—	—	—	$4.2m

26 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment

UNAIDS AIDSinfo

People living with HIV
People on treatment

Year	People living with HIV	People living with HIV (lower)	People living with HIV (upper)	People on treatment
2000	42,000	37,000	47,000	—
2001	74,000	66,000	82,000	—
2002	110,000	100,000	130,000	—
2003	150,000	140,000	170,000	—
2004	190,000	170,000	210,000	—
2005	230,000	210,000	260,000	—
2006	280,000	250,000	310,000	—
2007	320,000	280,000	350,000	—
2008	350,000	320,000	390,000	—
2009	390,000	350,000	420,000	—
2010	420,000	380,000	460,000	20,000
2011	450,000	410,000	490,000	25,000
2012	480,000	430,000	520,000	31,000
2013	500,000	450,000	540,000	38,000
2014	520,000	470,000	560,000	50,000
2015	530,000	480,000	580,000	63,000
2016	540,000	490,000	590,000	78,000
2017	550,000	500,000	600,000	91,000
2018	560,000	510,000	610,000	110,000
2019	560,000	510,000	610,000	130,000
2020	570,000	520,000	620,000	140,000
2021	570,000	520,000	620,000	150,000
2022	570,000	520,000	620,000	160,000
2023	570,000	520,000	620,000	180,000
2024	570,000	520,000	620,000	230,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade

UNAIDS AIDSinfo

On treatment

Year	On treatment
2010	5.0%
2011	6.0%
2012	7.0%
2013	8.0%
2014	10.0%
2015	12.0%
2016	14.0%
2017	16.0%
2018	19.0%
2019	22.0%
2020	25.0%
2021	27.0%
2022	29.0%
2023	31.0%
2024	41.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

What service users reported, 2026

CLM Asia · selected facilities

Question put to service users	Value
Service user knows own viral load	98.1%
Facility opens and closes on time	94.6%
Enough staff to meet the needs of service users	91.8%
Psychosocial support available for PLHIV	72.4%
Paid out of pocket for medicines or tests in the last six months	13.2%
Faced stigma or discrimination at the facility in the last six months	0.6%
Left facility without ARV or OI medicines because of a stockout in the last three months	0.2%

7 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Pooled responses from service users at a small number of facilities in the Jakarta area. The responses come from selected facilities and are not a national estimate, and whether a higher or a lower percentage signals a problem differs from question to question.

Data-quality flags on Indonesia

HIV tests performed with the result returned to the person, 2019 (PEPFAR Panorama Spotlight). The value moved from 88,633 in 2018 to 379,868 in 2019, a change of more than threefold in a single year. The move from 88,633 to 379,868 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2018 and 2019 are not comparable. Check the figures by reporting organisation before reading a trend across 2018 and 2019.

Sources of the figures for Indonesia

3,366 rows

Source	Type	Rows	Indicators	Years	Read from	Retrieved
UNICEF HIV/AIDS dataset	Modelled estimate	1,376	5	2010–2025	sdmx.data.unicef.org	2026-10-20
UNAIDS AIDSinfo	Modelled estimate	611	27	2000–2024	aidsinfo.unaids.org	2026-10-20
WHO Global Health Observatory	Modelled estimate	246	12	2000–2025	ghoapi.azureedge.net	2026-10-12
WHO Global Tuberculosis Programme	Programme record	187	17	2000–2025	extranet.who.int	2026-10-16
PEPFAR results by province	Programme record	113	7	2016–2025	data.pepfar.gov	2026-10-12
Global Fund Data Service	Programme record	111	12	2017–2025	fetch.theglobalfund.org	2026-10-12
UNAIDS Global AIDS Monitoring expenditure database	Expenditure account	107	18	2015–2022	hivfinancial.unaids.org	2026-10-12
ForeignAssistance.gov	Expenditure account	73	4	2001–2026	foreignassistance.gov	2026-10-29
Demographic and Health Surveys	Survey	71	1	2012–2017	api.dhsprogram.com	2026-10-16
OECD Creditor Reporting System	Expenditure account	67	3	2002–2024	sdmx.oecd.org	2026-10-12
IATI, through d-portal	Expenditure account	64	3	2001–2026	d-portal.org	2026-10-12
PEPFAR results by funding agency and province	Programme record	54	3	2018–2025	data.pepfar.gov	2026-10-12
World Bank Open Data	Modelled estimate	51	2	2000–2025	api.worldbank.org	2026-10-12
WHO HIV testing services dashboard	Programme record	46	4	2018–2024	eic-database-290813.ew.r.appspot.com	2026-10-14
PEPFAR Panorama Spotlight	Programme record	41	6	2018–2025	data.pepfar.gov	2026-10-12
PEPFAR testing by modality	Programme record	32	4	2018–2025	data.pepfar.gov	2026-10-12
CLM Asia	Community-led monitoring	30	8	2023–2026	data.clm-asia.org	2026-10-14
PEPFAR results by funding agency	Programme record	24	3	2018–2025	data.pepfar.gov	2026-10-12
PEPFAR budgets and expenditure	Expenditure account	24	6	2021–2025	data.pepfar.gov	2026-10-12
PEPFAR operating-unit budgets	Expenditure account	17	2	2007–2020	data.pepfar.gov	2026-10-12
UNAIDS Data 2025 country databook	Expenditure account	14	3	2015–2020	aidsinfo.unaids.org	2026-10-15
Global Fund allocations	Expenditure account	4	1	2017–2026	fetch.theglobalfund.org	2026-10-12
PEPFAR human resources for health inventory	Expenditure account	3	3	2025	data.pepfar.gov	2026-10-12

Indicators held

101 of 150

Indicator	Domain	Unit	Rows	Years	Sources	Most recent value
Actual expenditure on collaborative TB/HIV activities	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$583k (2024)
Budget required for collaborative TB/HIV activities	Financing	USD	8	2018–2025	WHO Global Tuberculosis Programme	$14.4m (2025)
Country-reported HIV expenditure, all sources	Financing	USD	15	2012–2022	UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database	$156.9m (2022)
Domestic funding received by the national TB programme	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$94.9m (2024)
Domestic public HIV expenditure	Financing	USD	13	2015–2022	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$108.3m (2022)
Expected Global Fund funding for the national TB programme	Financing	USD	8	2018–2025	WHO Global Tuberculosis Programme	$63.2m (2025)
Expected USAID funding for the national TB programme	Financing	USD	7	2018–2024	WHO Global Tuberculosis Programme	$21.0m (2024)
Expected domestic funding for the national TB programme	Financing	USD	8	2018–2025	WHO Global Tuberculosis Programme	$284.4m (2025)
Expected funding for collaborative TB/HIV activities	Financing	USD	8	2018–2025	WHO Global Tuberculosis Programme	$1.6m (2025)
External HIV financing (all donors, ODA)	Financing	USD	23	2002–2024	OECD Creditor Reporting System	$36.1m (2024)
External HIV financing from governments other than the United States (IATI)	Financing	USD	26	2001–2026	IATI, through d-portal	$36k (2026)
External HIV financing from multilateral bodies other than the Global Fund (IATI)	Financing	USD	15	2012–2026	IATI, through d-portal	$3.2m (2026)
External HIV financing from the United States (ODA)	Financing	USD	49	2001–2026	ForeignAssistance.gov, OECD Creditor Reporting System	$4.2m (2026)
Funding received for collaborative TB/HIV activities	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$899k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure	Financing	USD per three-year allocation cycle	4	2017–2026	Global Fund allocations	63,782,332 (2026)
Global Fund HIV disbursements to the country	Financing	USD	51	2003–2026	IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database	$13.0m (2026)
Global Fund funding received by the national TB programme	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$81.7m (2024)
HIV spending on TB/HIV co-infection	Financing	USD	4	2019–2022	UNAIDS Global AIDS Monitoring expenditure database	$5.3m (2022)
HIV spending on community mobilisation and system strengthening	Financing	USD	5	2015–2020	UNAIDS Global AIDS Monitoring expenditure database	$1.2m (2020)
HIV spending on critical enablers	Financing	USD	7	2015–2022	UNAIDS Global AIDS Monitoring expenditure database	$2.5m (2022)
HIV spending on gender programmes	Financing	USD	7	2015–2022	UNAIDS Global AIDS Monitoring expenditure database	$102k (2022)
HIV spending on governance and sustainability	Financing	USD	7	2015–2022	UNAIDS Global AIDS Monitoring expenditure database	$20.2m (2022)
HIV spending on prevention	Financing	USD	7	2015–2022	UNAIDS Global AIDS Monitoring expenditure database	$17.3m (2022)
HIV spending on prevention of vertical transmission	Financing	USD	7	2015–2022	UNAIDS Global AIDS Monitoring expenditure database	$191k (2022)
HIV spending on programmes for children and adolescents	Financing	USD	6	2017–2022	UNAIDS Global AIDS Monitoring expenditure database	$1.6m (2022)
HIV spending on social protection and economic support	Financing	USD	6	2017–2022	UNAIDS Global AIDS Monitoring expenditure database	$250k (2022)
HIV spending on treatment, care and support	Financing	USD	7	2015–2022	UNAIDS Global AIDS Monitoring expenditure database	$109.5m (2022)
International HIV expenditure (country-reported)	Financing	USD	13	2015–2022	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$47.6m (2022)
Other bilateral HIV expenditure (country-reported)	Financing	USD	2	2017–2018	UNAIDS Global AIDS Monitoring expenditure database	$214k (2018)
Out-of-pocket HIV expenditure by households	Financing	USD	4	2017–2022	UNAIDS Global AIDS Monitoring expenditure database	$495k (2022)
PEPFAR expenditure, USAID	Financing	USD	5	2021–2025	PEPFAR budgets and expenditure	$5.6m (2025)
PEPFAR expenditure, all US agencies	Financing	USD	14	2017–2025	PEPFAR budgets and expenditure, PEPFAR operating-unit budgets, UNAIDS Global AIDS Monitoring expenditure database	$5.6m (2025)
PEPFAR expenditure, other US agencies	Financing	USD	2	2021–2022	PEPFAR budgets and expenditure	$0 (2022)
PEPFAR planned funding (budget), all US agencies	Financing	USD	19	2007–2025	PEPFAR budgets and expenditure, PEPFAR operating-unit budgets	$10.8m (2025)
PEPFAR planned funding, USAID	Financing	USD	5	2021–2025	PEPFAR budgets and expenditure	$10.8m (2025)
PEPFAR planned funding, other US agencies	Financing	USD	2	2021–2022	PEPFAR budgets and expenditure	$88k (2022)
PEPFAR spend on staff, human resources for health inventory	Financing	USD	1	2025	PEPFAR human resources for health inventory	$3.0m (2025)
PEPFAR-funded staff delivering services, full-time equivalents	Financing	count	1	2025	PEPFAR human resources for health inventory	90 (2025)
PEPFAR-funded staff, full-time equivalents	Financing	count	1	2025	PEPFAR human resources for health inventory	169 (2025)
Private HIV expenditure (country-reported)	Financing	USD	6	2017–2022	UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database	$1.1m (2022)
US HIV disbursements managed by USAID	Financing	USD	26	2001–2026	ForeignAssistance.gov	$529 (2026)
US HIV disbursements managed by other US agencies	Financing	USD	19	2005–2023	ForeignAssistance.gov	$0 (2023)
US HIV disbursements managed by the State Department	Financing	USD	2	2025–2026	ForeignAssistance.gov	$4.2m (2026)
USAID funding received by the national TB programme	Financing	USD	8	2017–2024	WHO Global Tuberculosis Programme	$19.5m (2024)
% of ALL PLHIV who are virally suppressed	Treatment cascade	percent	5	2023–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	45.0% (2025)
% of PLHIV on ART (second 95, PLHIV base)	Treatment cascade	percent	72	2000–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	48.0% (2025)
% of PLHIV who have been diagnosed (first 95)	Treatment cascade	percent	7	2024–2025	UNAIDS AIDSinfo, WHO Global Health Observatory	67.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART	Treatment cascade	percent	16	2009–2024	UNAIDS AIDSinfo	29.0% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy	Treatment cascade	percent	4	2018–2024	UNAIDS AIDSinfo	8.9% (2024)
% of people living with HIV on ART who completed a course of TB preventive therapy	Treatment cascade	percent	1	2024	UNAIDS AIDSinfo	61.3% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease	Treatment cascade	percent	10	2013–2024	UNAIDS AIDSinfo	2.8% (2024)
% of people newly enrolled in HIV treatment started on TB preventive therapy	Treatment cascade	percent	9	2015–2024	UNAIDS AIDSinfo	9.0% (2024)
% of people on ART who are virally suppressed (third 95)	Treatment cascade	percent	20	2017–2025	PEPFAR results by province, WHO Global Health Observatory	95.0% (2025)
% of returned HIV test results that were positive	Treatment cascade	percent	34	2018–2024	UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard	0.9% (2024)
HIV self-test kits distributed	Treatment cascade	count	4	2020–2024	WHO HIV testing services dashboard	200,299 (2024)
HIV tests performed at a health facility	Treatment cascade	count	14	2018–2025	PEPFAR testing by modality, WHO HIV testing services dashboard	37,797 (2025)
HIV tests performed with the result returned to the person	Treatment cascade	count	75	2016–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard	37,797 (2025)
HIV-exposed infants tested within two months of birth	Treatment cascade	percent	12	2013–2024	UNAIDS AIDSinfo	13.0% (2024)
HIV-positive TB patients started or continued on ART	Treatment cascade	count	24	2015–2025	Global Fund Data Service, WHO Global Tuberculosis Programme	10,912 (2025)
Key-population people tested for HIV (count over the period)	Treatment cascade	count	36	2017–2025	Global Fund Data Service	By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200	Treatment cascade	percent	5	2015–2019	UNAIDS AIDSinfo	52.0% (2019)
Newly diagnosed at USAID-funded partners (MER HTS_TST_POS)	Treatment cascade	count	26	2018–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	1,244 (2025)
Newly enrolled on ART at USAID-funded partners (MER TX_NEW)	Treatment cascade	count	26	2018–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	1,523 (2025)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS)	Treatment cascade	count	35	2016–2025	PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality	1,244 (2025)
Number of PLHIV virally suppressed (VL<1000)	Treatment cascade	count	25	2017–2025	PEPFAR Panorama Spotlight, PEPFAR results by province	41,444 (2025)
Number of people on ART (PEPFAR MER TX_CURR)	Treatment cascade	count	105	2000–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme	266,681 (2025)
PMTCT ART coverage among pregnant women with HIV	Treatment cascade	percent	16	2010–2025	UNICEF HIV/AIDS dataset	64.0% (2025)
People living with HIV in care screened for TB	Treatment cascade	count	9	2017–2025	Global Fund Data Service	50,176 (2025)
People living with HIV on ART who started TB preventive therapy	Treatment cascade	count	9	2017–2025	Global Fund Data Service	27,222 (2025)
People newly diagnosed at a health facility	Treatment cascade	count	8	2018–2025	PEPFAR testing by modality	1,244 (2025)
People newly enrolled on ART during the year	Treatment cascade	count	40	2013–2025	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, WHO Global Tuberculosis Programme	1,523 (2025)
People on ART at USAID-funded partners (MER TX_CURR)	Treatment cascade	count	26	2018–2025	PEPFAR results by funding agency, PEPFAR results by funding agency and province	51,428 (2025)
People who completed a course of TB preventive therapy	Treatment cascade	count	2	2024–2025	Global Fund Data Service	56,057 (2025)
Pregnant women tested for HIV in antenatal care	Treatment cascade	percent	9	2015–2024	UNAIDS AIDSinfo	91.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT	Treatment cascade	count	36	2010–2025	Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory	2,082 (2025)
TB patients recorded as HIV-positive	Treatment cascade	count	15	2015–2024	WHO Global Tuberculosis Programme	17,706 (2024)
TB patients with an HIV test result recorded	Treatment cascade	count	24	2015–2025	Global Fund Data Service, WHO Global Tuberculosis Programme	638,458 (2025)
AIDS-related deaths	Epidemic estimates	count	631	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	18,000 (2025)
Deaths from TB among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	8,100 (2024)
HIV prevalence among a key population	Epidemic estimates	percent	5	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
HIV prevalence, ages 15-49	Epidemic estimates	percent	50	2000–2024	UNAIDS AIDSinfo, World Bank Open Data	0.4% (2024)
Incident TB cases among people living with HIV	Epidemic estimates	count	50	2000–2024	UNAIDS AIDSinfo, WHO Global Tuberculosis Programme	33,000 (2024)
New HIV infections	Epidemic estimates	count	535	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	21,000 (2025)
People living with HIV	Epidemic estimates	count	631	2000–2025	UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory	560,000 (2025)
Key-population members reached by prevention programmes	Prevention and outreach	percent	4	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period)	Prevention and outreach	count	13	2017–2023	Global Fund Data Service	By population group, sex or age only, to 2023
Male condoms distributed in a year	Prevention and outreach	count	5	2019–2024	UNAIDS AIDSinfo	12,540,877 (2024)
People receiving PrEP	Prevention and outreach	count	9	2022–2024	Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, UNAIDS AIDSinfo	40,000 (2024)
People with comprehensive correct knowledge of HIV (household survey)	Prevention and outreach	percent	71	2012–2017	Demographic and Health Surveys	By population group, sex or age only, to 2017
Enough staff to meet the needs of service users (CLM)	Service access	percent	4	2023–2026	CLM Asia	91.8% (2026)
Ever stopped antiretroviral treatment (CLM)	Service access	percent	2	2023–2024	CLM Asia	11.9% (2024)
Faced stigma or discrimination at the facility in the last six months (CLM)	Service access	percent	4	2023–2026	CLM Asia	0.6% (2026)
Facility opens and closes on time (CLM)	Service access	percent	4	2023–2026	CLM Asia	94.6% (2026)
Left facility without ARV or OI medicines because of a stockout in the last three months (CLM)	Service access	percent	4	2023–2026	CLM Asia	0.2% (2026)
Paid out of pocket for medicines or tests in the last six months (CLM)	Service access	percent	4	2023–2026	CLM Asia	13.2% (2026)
Psychosocial support available for PLHIV (CLM)	Service access	percent	4	2023–2026	CLM Asia	72.4% (2026)
Service user knows own viral load (CLM)	Service access	percent	4	2023–2026	CLM Asia	98.1% (2026)
Estimated pregnant women with HIV needing ARVs for PMTCT	Population denominators	count	16	2010–2025	WHO Global Health Observatory	3,300 (2025)
Estimated size of a key population	Population denominators	count	5	2024	UNAIDS AIDSinfo	By population group, sex or age only, to 2024
Total population	Population denominators	count	26	2000–2025	World Bank Open Data	285,721,236 (2025)
Share of HIV-exposed infants who acquire HIV	—	percent	16	2010–2025	UNICEF HIV/AIDS dataset	19.7% (2025)

Every row shown on the Indonesia page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.